What This Means
This research suggests that it is now possible to measure six key metabolites involved in the body's energy and antioxidant systems — NAD+, NADH, NADP+, NADPH, glutathione (GSH), and oxidized glutathione (GSSG) — all from a single blood sample using a standardized laboratory method. By applying this method to healthy adults between ages 18 and 70, the researchers found that these metabolite levels are normally distributed in the population and do not significantly change with age within this range, establishing for the first time what 'healthy' blood levels of these molecules look like in humans. This is important because until now, no such reference values existed, making it difficult to interpret whether a patient's levels were abnormal.
The study also found that when healthy people took high doses of nicotinic acid (a form of vitamin B3 marketed as an NAD+ booster), their blood NAD+ levels rose dramatically — by 4 to 6 times — but the response varied considerably between individuals. This research suggests that one-size-fits-all dosing of NAD+ supplements may be inadequate, and that personalized monitoring may be needed during treatment or clinical trials. Additionally, different diseases — including various cancers and other degenerative conditions — showed distinct patterns, or 'redox fingerprints,' across these six metabolites, suggesting that this type of blood test could potentially help identify disease states or track how well a treatment is working.
Overall, this work lays the groundwork for using blood redox profiling as a practical clinical tool. By knowing what normal looks like and how specific diseases and treatments alter these metabolite profiles, clinicians and researchers may be better equipped to detect pathology early, monitor disease progression, and evaluate the effectiveness of therapies that target the body's redox systems.